Antiepileptic drug pharmacokinetics during pregnancy and lactation.
about
Management of epilepsy in womenPregnancy-Associated Changes in Pharmacokinetics: A Systematic ReviewEnsuring the safe and effective use of medications during pregnancy: planning and prevention through preconception careEURAP outcomes for seizure control during pregnancy: useful and encouraging data.Hormonal aspects of epilepsy.MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATION.Carbamazepine clearance and seizure stability during pregnancy.Is breast milk the best for babies of mothers on levetiracetam?The treatment of women with epilepsy.Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest?The pharmacology of bipolar disorder during pregnancy and breastfeeding.Transfer of dexamphetamine into breast milk during treatment for attention deficit hyperactivity disorder.Women and epilepsy.Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers.Therapy insight: clinical management of pregnant women with epilepsy.Therapeutic monitoring of antiepileptic drugs during pregnancy and in the postpartum period: is it useful?2005 AES annual course: evidence used to treat women with epilepsy.Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.Changes in antidepressant metabolism and dosing across pregnancy and early postpartumWomen and epilepsy: review and practical recommendations.Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymesAntiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy.Teratogenicity of antiepileptic medications.Truly "rational" polytherapy: maximizing efficacy and minimizing drug interactions, drug load, and adverse effects.Treatment of cluster headache in pregnancy and lactation.Profile of retigabine-induced neuronal apoptosis in the developing rat brain.Valproate semisodium ER for migraine and cluster headache prophylaxis.Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications.Treating epilepsy in pregnant women.Management of women with epilepsy: from preconception to post-partum.Update on management of epilepsy in women for the non-neurologist.Pharmacokinetics of antiepileptic drugs in pregnancy.Pharmacokinetic studies in pregnant women.Treatment considerations during pregnancy for women with epilepsy.Levetiracetam concentrations in serum and in breast milk at birth and during lactation.Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium.Newer anticonvulsants: lamotrigine, topiramate and gabapentin.Impact of pregnancy on zonisamide pharmacokinetics in rabbits.Effect of pregnancy on topiramate pharmacokinetics in rabbits.Clinical characteristics and management of bipolar disorder in women across the life span.
P2860
Q24680158-84488A06-95C2-46C0-87CD-7EA5B1BFCF53Q28109657-4E362E88-3D72-477B-B8F7-0B54FF135344Q28199588-B3B50AE1-20A5-47A7-8E68-6F61FBE37C85Q33270669-CF02A2CF-C774-4410-BC7A-26EB5BD408FFQ33638313-1632A22F-DED6-4B09-8B36-F1BCB7F7B8B6Q33683865-EAB6B5F2-6DA7-4658-B799-8E1D6BA26792Q33696210-57FE7007-C763-4C92-A41D-B1CB5F4E3D92Q34342613-4954D03D-7A98-4035-B2AA-D6107B9F8B33Q34363064-4D2B5114-A8CD-4C15-97C0-940B54B760CFQ34905287-8A392D01-461B-44C2-8B4C-BA3300A9B19FQ35779335-D3730BA1-01DA-49D8-BB30-4274CEF5DB63Q36024999-5DEEF124-6963-4716-ADED-65CE6BE6218FQ36287145-C746ACAA-562B-4BD6-8F0D-0838D4D9CDCFQ36476778-044726BC-566A-4B5E-A6C5-8D534C62378BQ36577270-DD77FA2F-5345-456C-B2E8-512149C2A635Q36603158-889AFB88-51F3-479A-BC1A-1620C4F79650Q36625015-DBF76DB0-1279-4771-8E10-63D9BE57B9C2Q36660112-82098630-B6DB-4238-AC98-6D83051F79CEQ36692162-E4A75CAE-E028-4EF8-BED0-68C17AE1FD89Q36752925-485691C4-47FB-449B-99F9-BA8ED2329D9EQ36939547-926EE68C-FE33-416F-A4F3-CD38D203818EQ37179423-6B48B789-181F-4BDC-9B32-83E2657BC3ADQ37262946-F60CE092-6B6D-489A-A373-A890509C4418Q37313454-2E55490E-FD77-4C9B-B258-8D35195DCB9AQ37377970-212B5DC4-4790-4466-8F79-85164E2F28DBQ37559363-927B3619-47BF-48A2-94F4-6EC2B48D4DDDQ37713736-BFF7F9D4-EB05-42CD-A210-373CF676D6F1Q38077586-0176D530-FC41-4B5E-BFF5-340D1A2C7E8CQ38194574-F0BBBB03-8AEA-4078-9909-08E64961B557Q38655275-AABB3210-27B3-4409-8448-978B1D5DA67AQ38895955-C32BC7DA-6CFB-42C3-A752-8F4CCF34BBA7Q40138489-295826A0-7D9A-4279-8D94-E2258D0C4C35Q42007783-20A9DD52-30C8-4945-A383-183949D54C2DQ43267058-23CE5923-258B-43F7-890C-7D677482C6A3Q46460413-9CDF5A8C-30A3-4626-B928-398BED338930Q46984904-58BB0791-56FD-4E34-80A2-7C240F7E05DAQ50799679-C13156C2-C362-4D3E-9DA7-548687DF7108Q51166297-710B611F-5BF7-43BA-9158-5562764D182BQ51512151-2E091B8E-A276-41DC-A3CF-F8E292BC992BQ51834824-2346CB21-E3F4-441F-8B52-3277F355ADF4
P2860
Antiepileptic drug pharmacokinetics during pregnancy and lactation.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Antiepileptic drug pharmacokinetics during pregnancy and lactation.
@ast
Antiepileptic drug pharmacokinetics during pregnancy and lactation.
@en
type
label
Antiepileptic drug pharmacokinetics during pregnancy and lactation.
@ast
Antiepileptic drug pharmacokinetics during pregnancy and lactation.
@en
prefLabel
Antiepileptic drug pharmacokinetics during pregnancy and lactation.
@ast
Antiepileptic drug pharmacokinetics during pregnancy and lactation.
@en
P1433
P1476
Antiepileptic drug pharmacokinetics during pregnancy and lactation.
@en
P2093
Page B Pennell
P304
P356
10.1212/WNL.61.6_SUPPL_2.S35
P407
P433
P577
2003-09-01T00:00:00Z